Scientists have found blood protein signals that may flag multiple sclerosis up to seven years before symptoms begin.

Multiple sclerosis is a disease that affects the central nervous system and is considered an autoimmune disease, in which the immune system attacks its own healthy cells. It affects quality of life ...

Researchers have traced the earliest stages of multiple sclerosis (MS), showing that the immune system begins attacking the brain up to seven years before diagnosis.

Multiple sclerosis (MS) is primarily recognised as a chronic demyelinating disease of the central nervous system, yet its impact extends to the autonomic nervous system (ANS), which governs vital ...

"Multiple sclerosis: three trials to watch" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

By the time patients start seeking care for multiple sclerosis (MS), the disease has already been damaging their brains for ...

By the time patients start seeking care for multiple sclerosis (MS), the disease has already been damaging their brains for ...

Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...

Both Guillain-Barré syndrome and multiple sclerosis involve an autoimmune attack on the nervous system. Guillain-Barré syndrome affects the peripheral nervous system, while multiple sclerosis impacts ...

Scientists have found that people with multiple sclerosis (MS) have a distinctly imbalanced oral microbiome—marked by a loss of beneficial bacteria and a rise in inflammation-linked microbes.

Zenas BioPharma shares jumped in premarket trading after the company reported highly positive trial data for its multiple-sclerosis treatment. Shares traded over 59% higher ahead of the morning bell ...